<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://repozitorij.uni-lj.si/IzpisGradiva.php?id=132772"><dc:title>THP-1 cells and pro-inflammatory cytokine production</dc:title><dc:creator>Jakopin,	Žiga	(Avtor)
	</dc:creator><dc:creator>Corsini,	Emanuela	(Avtor)
	</dc:creator><dc:subject>THP-1</dc:subject><dc:subject>cytokines</dc:subject><dc:subject>IL-8</dc:subject><dc:subject>TNF-α</dc:subject><dc:subject>immunomodulation</dc:subject><dc:subject>NOD1 antagonist</dc:subject><dc:subject>NOD2 antagonist</dc:subject><dc:subject>functional characterization</dc:subject><dc:description>THP-1 cells express high levels of native functional nucleotide-binding oligomerization domain 1 (NOD1), NOD2, and Toll-like receptor 4 (TLR4) receptors, and have often been used for investigating the immunomodulatory effects of small molecules. We postulated that they would represent an ideal cell-based model for our study, the aim of which was to develop a new in vitro tool for functional characterization of NOD antagonists. NOD antagonists were initially screened for their effect on NOD agonist-induced interleukin-8 (IL-8) release. Next, we examined the extent to which the selected NOD antagonists block the NOD-TLR4 synergistic crosstalk by measuring the effect of NOD antagonism on tumor necrosis factor-α (TNF-α) secretion from doubly activated THP-1 cells. Overall, the results obtained indicate that pro-inflammatory cytokine secretion from THP-1 provides a valuable, simple and reproducible in vitro tool for functional characterization of NOD antagonists.</dc:description><dc:date>2019</dc:date><dc:date>2021-11-03 08:26:37</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>132772</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
